Understanding bone healing issues in children with Neurofibromatosis Type 1
Etiology of musculoskeletal maladies in NF1
This study is looking into why kids with Neurofibromatosis Type 1 have trouble healing their bones, especially when they have bowing in their legs, and it’s testing a new treatment that might help their bones heal better by getting rid of certain bad cells.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Baylor College of Medicine NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-11042807 on NIH RePORTER |
What this research studies
This research investigates why children with Neurofibromatosis Type 1 (NF1) experience poor bone healing, particularly in cases of tibial bowing that can lead to fractures. The study focuses on the role of specific bone cells that are affected by NF1, which may lead to chronic signaling issues that hinder normal bone repair. By exploring the use of senolytic drugs to eliminate problematic cells, the research aims to improve bone healing outcomes for these children. The approach involves both genetic and pharmacological methods to assess the effectiveness of clearing these cells in promoting better bone union.
Who could benefit from this research
Good fit: Ideal candidates for this research are children diagnosed with Neurofibromatosis Type 1 who are experiencing bone healing complications.
Not a fit: Patients without Neurofibromatosis Type 1 or those not experiencing bone healing issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved healing of bone fractures in children with NF1, potentially reducing the need for invasive surgeries and amputations.
How similar studies have performed: While the approach of using senolytic drugs is innovative, similar strategies targeting cellular senescence have shown promise in other contexts, suggesting potential for success in this area.
Where this research is happening
Houston, United States
- Baylor College of Medicine — Houston, United States (Active)
Researchers
- Principal investigator: Elefteriou, Florent — Baylor College of Medicine
- Study coordinator: Elefteriou, Florent
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.